The FDA has accepted for review a “new” migraine drug, Trexima, that was developed by Pozen for sale by GlaxoSmithKline. Trexima is a combination of sumitriptan (Imitrex) and naproxen sodium (the ingredient in Aleve). Hmm, could this be GSK’s desperate attempt to hold the patent…
Aetna announced plans to launch a pilot program that will put ATM-like machines that will dispense samples of generic drugs in doctors’ offices. Medications for depression and high blood pressure are among those that will be stocked in the machine. Using an access code, doctors…
The results of a recent study on high blood pressure meds and headache raises the question if headaches are vascular or neurological. The study authors did a meta-analysis, which is a review of previously published research. In the 94 studies of four different kids of…
In a recent study of antidepressants and birth defects, Paxil was linked to twice as many birth defects as other antidepressants. Company officials are quick to point out that the study doesn’t show if Paxil actually had a role in the birth defects, but if…
A device that sends pressurized carbon dioxide up one nostril and out the other, without the patient inhaling it, appears to abort migraines rapidly and effectively. Findings from the Phase II study on the device were reported at this week’s annual meeting of the American…